Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0K2CR
|
||||
Former ID |
DIB015003
|
||||
Drug Name |
Nemorubicin
|
||||
Synonyms |
Nemorubicinol; FCE-23762; PNU-152243; PNU-156685; PNU-156686; PNU-159682
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Preclinical | [547011] | ||
Company |
Pharmacia & Upjohn AB
|
||||
Structure |
Download2D MOL |
||||
Formula |
C32H37NO13
|
||||
Canonical SMILES |
c12c(C(=O)c3c(C1=O)cccc3OC)c(c1c(c2O)C[C@](C[C@@H]1O[C@<br />H]1C[C@H](N2C[C@H](OCC2)OC)[C@@H]([C@@H](O1)C)O)(C(=O)C<br />O)O)O
|
||||
CAS Number |
CAS 108852-90-0
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | DNA topoisomerase II | Target Info | Modulator | [532120] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.